ãããå¦ãã«ã¤ãã¦
éåå¨OTåå¼·ä¼
æ¥æï¼å¹³æ25å¹´12æ5æ¥ï¼æ¨ï¼ã18æï½19æ
å 容ï¼
ã1ï¼è¨ºæåºæº
ã2ï¼è©ä¾¡
ã3ï¼äºæ¸¬å å
ã4ï¼äºé²
Â
ããå¦ã¨ã¯ï¼
ãããå¦ï¼ãããããè«å¦ãdeliriumï¼ã¯ãæèæ··æ¿ã«å ãã¦å¹»è¦ãé¯è¦ãè¦ããããããªç¶æ ãå¥åº·ãªäººã§ãå¯ã¦ãã人ãå¼·å¼ã«èµ·ããã¨åãçç¶ãèµ·ãããICUãCCUã§ç®¡çããã¦ããæ£è ã«ããèµ·ããã
ãæ¥æ¿ãªç²¾ç¥éåè奮ï¼ã«ãã¼ãã«ãå¼ãæããªã©ï¼ããå診ä¸æãããªè¦å½èé害ã§æ°ãã¤ããããã¨ãå¤ãã 大æè¡å¾ã®æ£è ï¼è¡å¾ããå¦ï¼ãã¢ã«ããã¤ãã¼ç ãè³åä¸ã代è¬é害ãã¢ã«ã³ã¼ã«ä¾åçã®æ£è ã«ãã¿ãããã
ï¼Wikipediaï¼
Â
診æåºæº
å®ç¾©ï¼DSM-â £ï¼
Aï¼æèé害ã®ããã«å¨å²ãèªèããæèçå½åº¦ãä½ä¸ãã¦ããã注æãéä¸ã»ç¶æã»è»¢æããè½åã®ä½ä¸ãä¼´ã
Bï¼èªç¥è½åã®å¤åï¼è¨éåä½ä¸ãè¦å½èé害ãè¨èªè½åã®é害ãªã©ï¼ããããã¯ç¥è¦è½åã®é害ãåºç¾ãããããããã¯ãã§ã«åå¨ãã¦ããç´åã«ãã£ã¦ã¯ãã説æã§ããªã
Cï¼ãã®é害ã¯çæéï¼é常æ°æéããæ°æ¥ï¼ã«çºç¾ããä¸æ¥ã®ãã¡ã§å¤åãã
Dï¼ç æ´ã診å¯ããããã¯æ¤æ»ãã¼ã¿ãæ ¹æ ã«ç´æ¥ã®åå ãç¹å®ãã
ã1ï¼ä½ç¾æ£ã2ï¼è¬ç©ã»ç©è³ªã«ããä¸æ¯ã3ï¼é¢è±æ§ã4ï¼å¤è¦å æ§ã5ï¼ãã®ä»
Â
å®ç¾©ï¼Confusion Assessment Methods (CAM)Â
â æ¥æ§ã®çºçã¨çç¶ã®åæº
â¡æ³¨æåã®æ¬ å¦
â¢æèã®é¯ä¹±
â£æèã¬ãã«ã®å¤å
2ã¤ç®ã¾ã§ã¯å¿ é é ç®ã§ããããã¨ã²ã¨ã¤ãã¿ããã°è¨ºæãã¦ããã
Â
ããå¦ã®çç¶
1ï¼æèã¨æ³¨æã®é害ï¼ä¸æ ¸çç¶
ãa.ãæèï¼èªå·±ã¨å¨å²ã®ç¶æ³ã«å¯¾ããèªè
ãb.ã注æã®è¦ç´ ï¼é¸ææ§ãæç¶æ§ã転å°æ§ãå¤æ¹åæ§ãæåæ§
2ï¼è¦é度ã®é害ï¼äº¢é²ã¨ä½ä¸ãä¸è¦åã«å¤å
3ï¼ç¡ç ï¼è¦éãªãºã ã®é害ï¼æ¼éã®ç æ°ãå¤éã®ä¸ç©ãæ¼å¤é転
4ï¼è¨æ¶ã»è¦å½èé害
ãa.ãè¨æ¶ï¼ååå¥å¿ãéè¡å¥å¿ãè¨æ¶é¯èª¤
ãb.ãè¦å½èé害ï¼æéãå ´æã人ç©ã®é ã«é害ãéè¤ç¾è±¡
5ï¼ç¥è¦ã®é害ï¼è¦è¦ã®é害ãæãå¤ã
ããé¯è¦ãå¹»è¦ï¼è¦è¦ãè´è¦ã触è¦ãå è¦ãå³è¦
6ï¼è¨èªã®é害ï¼é¯èª¤ãçºè©±éã声éã¨ãæ´»åæ§ã¨ä¸¦è¡
7ï¼æèã®é害
ããä¸è²«æ§ã失ããç解ãå°é£ã§ãããã¨ãå¤ã
ããå 容ï¼è²§å°ãä¸é©åãå¦æ³çã被害ç
8ï¼æ°åã®æå¤æ§
9ï¼éåç¶æå°é£
10ï¼ç²¾ç¥éåæ§é害
ãa. Hyperactive type
ããè奮ãå¾å¾ãå¤å¼ãææ çã«ä¸å®å®
ããå¹»è¦ãå¦æ³ãæããã§ãæ²»çãè¡ãä¸ã§é£æ¸ãã
ãb. Hypoactive type
ããåç ãå¾ç å¾åã§è¥åºãã¦ããå ´åãå¤ã
ï¼èªäºè£å ï¼ããå¦ï¼æ¾ä¸æ£æãç·¨ï¼è¨åºç²¾ç¥å»å¦è¬åº§ãS7ï¼ç·å診çã«ãããç²¾ç¥å»å¦ï¼ä¸å±±æ¸åºï¼æ±äº¬ï¼2000ï¼104â115ï¼ï¼
Â
ãhypoactive typeã¯ãè¨åºçç¶ã«ä¹ããããã診æãå°é£ã§å»å¸«ãçè·å¸«ãªã©ã®å»çã¹ã¿ããã«è¦éããã¦ããå ´åãå¤ããã¡ãªã¿ã«ä¸è¬ç æ£ã§ã¯33ï½66ï¼ ã§è¦éããã¦ããã¨ããå ±åï¼1ï¼ããè¡å¾ã§ã¯å¤ç§å»ãçè·å¸«ã®è¨é²ã¨ç²¾ç¥ç§å»ã®è¨ºæã§ã¯28%ã§ããå¦ãè¦éããã¦ããã¨ããå ±åï¼2ï¼ãããã
ï¼å¤å®¶ä»ãç·¨èï¼è¡å¾ç²¾ç¥é害ãããå¦ãä¸å¿ã¨ãã対å¦æ³ï¼çè交æï¼æ±äº¬ï¼2003ï¼41â44ï¼ï¼
ï¼1ï¼Am J Med. 1994 Sep;97(3):278-88.
The dilemma of delirium: clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients.
Inouye SK.
ï¼2ï¼J Am Geriatr Soc. 1991 Aug;39(8):760-5.
Underdiagnosis and poor documentation of acute confusional states in elderly hip fracture patients.
Gustafson Y, Brännström B, Norberg A, Bucht G, Winblad B.
Â
ã©ã®ç¨åº¦è¦éããããï¼
Trained clinical researcher VS Nurse
â»æ£è ã«è¿ãNsã§ãhypo active typeã®ããå¦ã¯è¦éãããããã
Â
ããå¦ãè¦éãããè¦å
â»hypo active typeãæãå¤ãã
ï¼Nurses' Recognition of Delirium and Its Symptoms Comparison of Nurse and Researcher RatingsÂ
Arch Intern Med. 2001;161(20):2467-2473. doi:10.1001/archinte.161.20.2467.ï¼
Â
çºçç
å ¥é¢æ£è ã®çºççã¯10ï½30%
è¡å¾ç¼çãç°å¢å¤åãæææãªã©ããçºççã¯é«ããªã
å¿èæè¡ï¼ãå¹³å38.5%
æ´å½¢å¤ç§æè¡ï¼ãå¹³å47.3%
èºç§»æ¤æè¡ï¼ãå¹³å73.0%
ãã以å¤ã®æè¡ï¼ãå¹³å11.4%
ï¼è¡å¾ç²¾ç¥é害ãããå¦ãä¸å¿ã¨ãã対å¦æ³ã2003ï¼
Â
è©ä¾¡
ããå¦è©ä¾¡å°ºåº¦ï¼Delirium Rating Scale: DRSï¼
æ¥æ¬èªçNEECHAMæ··ä¹±/é¯ä¹±ã¹ã±ã¼ã«
CAM-ICUï¼The Confusion Assessment Method for the Intensive Care Unitï¼
ICDSCï¼Intensive Care Delirium Screening Checklistï¼
MADSï¼Memorial Delirium Assessment Scaleï¼
Â
ããå¦è©ä¾¡å°ºåº¦ï¼DRSï¼
ã»ããå¦ã®æç¡ã¨éç度ãè©ä¾¡
ã»10é ç®
ã»0ï½3ç¹
ã»32ç¹æºç¹ä¸20ç¹ä»¥ä¸ã¯ããå¦ã®çã
é ç®
1ï¼çç¶çºç¾ã®æéççµé
2ï¼ç¥è¦ã®é害
3ï¼å¹»è¦ã®ã¿ã¤ã
4ï¼å¦æ³
5ï¼ç²¾ç¥éåè奮
6ï¼èªç¥æ©è½æ¤æ»
7ï¼èº«ä½çç°å¸¸
8ï¼ç¡ç ã»è¦éå¨æã®é害
9ï¼ææ ä¸å®å®
10ï¼çç¶ã®å¤åæ§
Â
æ¥æ¬èªçNEECHAMæ··ä¹±/é¯ä¹±ã¹ã±ã¼ã«
ã»NEECHAM Confusion Scaleï¼NCSï¼
ã»1996å¹´Neelonãã«ãã£ã¦éçºããã観å¯æ³ã«ããããå¦ã®æ¸¬å®ã»è©ä¾¡ã¹ã±ã¼ã«
ã»èªç¥ã»æ å ±å¦çï¼è¡åï¼ççå¦çã³ã³ããã¼ã«ã®3ã¤ã®ãµãã¹ã±ã¼ã«ããæ§æ
ã»åè¨ç¹ï¼30ç¹æºç¹ï¼ã«ãã£ã¦ä¸ç¨åº¦ï½é度ã軽度ã¾ãã¯çºçåæãçºçã®å±éºæ§ãé«ããæ£å¸¸ã®4段éã«åé¡
ã»æ¥æ¬èªçã2000å¹´ã«ç¶¿è²«ããéçº
Â
CAM-ICU
ã»è©ä¾¡ããæç¹ã§ã®ããå¦ã®æç¡ãè©ä¾¡
ã»æ¿ç®¡ãæ°ç®¡åéã§çºå£°ã§ããªãæ£è ã«ã使ç¨ã§ãã
ã»è©ä¾¡ã«ãããæéãçã
ã»éç度ã®è©ä¾¡ãã§ããªã
ã»æ£è ã®ååãå¿ è¦
Â
ICDSC
ã»8æéãã¾ãã¯24æé以å ã®æ å ±ã«åºã¥ããããå¦ã®æç¡ãè©ä¾¡ã§ãã
ã»æ¿ç®¡ãæ°ç®¡åéã§çºå£°ã§ããªãæ£è ã«ã使ç¨ã§ãã
ã»è©ä¾¡ã«ãããæéãçã
ã»æ£è ã®ååãå¿ è¦ã¨ããªã
ã»è©ä¾¡è ãå®éã«è¦ãäºè±¡ä»¥å¤ã«è¨é²ã証è¨ãªã©ãããå¤æã§ãã
ã»ã«ãããªãå¤ã¯4ç¹
Â
MADS
ã»Breitbert Wãã1997å¹´ã«éçº
ã»ããå¦ã®éç度è©ä¾¡
ã»10é ç®ã30ç¹æºç¹
ã»æ¾å²¡ã2001å¹´ã«æ¥æ¬èªçãéçº
ã»ããå¦ã¨éããå¦ã®ã«ãããªãå¤ã¯10ç¹
ã»DRSãMMSEã¨ææãªç¸é¢
Â
è©ä¾¡ã®é »åº¦
ã»äºé²ï½¥æ©æçºè¦ã®ããã«ãä¸æ¥ã«1åã¯è¡ããã¨ãæã¾ãã
ã»æ£è ã®ç¶æ ãå¤åãããå度è©ä¾¡ãã
ã»CAM-ICU以å¤ã¯è¦³å¯ãè©ä¾¡ããé ç®ãå«ã¾ãã¦ãããæ£è ã®ç¶æ ãç確ã«è©ä¾¡ããããã«é©åãªè©ä¾¡ééããããå¿ è¦ããã
ã»æ¥æ¬èªçãã¼ãã£ã æ··ä¹±ã»é¯ä¹±ã¹ã±ã¼ã«ã§ã¯æä½æ°æéã¯æ£è ã®çµéã観å¯ããå®éã«æ¥å¸¸çæ´»æ´å©ãè¡ãè©ä¾¡ããããæ¨å¥¨
ã»ãã¼ã«ãç¨ããããå¦ã®è©ä¾¡ã§ã¯ã対象ã¨ããæ£è ã«é©ãããã®ãé¸æãããã¼ã«ã®ç®çãè©ä¾¡æ¹æ³ãæ£ããç解ãã¦æ´»ç¨ãããã¨ãéè¦
Â
ããå¦ã«é¢é£ããè¦å
Lipowskiãã®åé¡
Â
âæºåå å
ã»å¹´é½¢
ã»æ§å¥
ã»Body Mass Indexï¼BMIï¼
ã»èªç¥çã®æç¡
Â
âç´æ¥åå
ã»ããå¦ã®åå ã¨ãªã主è¦ãªç¾æ£
ã»ãã¤ã¿ã«ãµã¤ã³ã®å¤å
ã»çªç´ å°¿ç´ ãé»è§£è³ªã®ç°å¸¸
ã»Hbï¼ãã¢ã°ããã³ï¼ãHtï¼ãããã¯ãªããå¤ï¼ã®ä½ä¸
ã»H2ãããã«ã¼ã®ä½¿ç¨
Â
âèªçºå å
ã»æè¦æ©è½é害ã®æç¡
ã»å ¥é¢æ´ã»å ¥é¢ããæè¡ã¾ã§ã®æé
ã»ç¡ç ç¶æ³
ã»æè¡ã®ä¾µè¥²åº¦
ã»ã«ã¼ãé¡ã®æ°
ã»ä½åå¶éã®æç¡
Â
çºçäºæ¸¬
ã»å¤§è ¸çæè¡
ã»75æ³ä»¥ä¸ã®71çä¾
ã»è¡å¾ããå¦ã¯71ä¾ä¸16ä¾ï¼22.5ï¼ ï¼ã«çºç
ã»å¾æé«é½¢è å¤§è ¸çæè¡ä¾ã«ããã¦ãHDS-Rã¯è¡å¾ããå¦çºçäºæ¸¬ã«æç¨
âé¢é£å å
ã»HDS-Rï¼25ç¹
ã»BMI
ã»è³è¡ç®¡ç¾æ£ã®æç¡
ã»ç å¤å¸¸ç¨æ´
ï¼é«é½¢è å¤§è ¸çè¡å¾ããå¦çºçäºæ¸¬ã«ãããé·è°·å·å¼ç°¡æç¥è½è©ä¾¡ã¹ã±ã¼ã«ã®æç¨ãæ¥æ¬å¤§è ¸èéç å¦ä¼éèª 65(2), 43-50, 2012-02-01 ï¼
Â
ã»è ¹é¨å¤ç§æè¡
ã»75æ³ä»¥ä¸ã®84ä¾
ã»NEECHMã¹ã³ã¢
ã»48ä¾ï¼57.1%ï¼ãè¡å¾10æ¥ã¾ã§ã«20ç¹æªæºã示ãã
ã»è¡å¾ç¬¬3ç æ¥ã¾ã§ã®ããå¦çºçãå¤ã
âé¢é£å å
ã»å¹´é½¢
ã»MMSEï¼25ç¹
ã»NEECHAMï¼27ç¹
ï¼é«é½¢è è ¹é¨å¤ç§æè¡å¾ã®ããå¦ã«é¢ããç 究ãæ¥æ¬æ¶åå¨å¤ç§å¦ä¼éèª 42(7), 1349, 2009-07-01ï¼
Â
ã»é«é½¢è¡å¾æ£è 48å
ã»NEECHAM
ã»è¡åããè¡å¾5æ¥ç®ã¾ã§
ã»ããå¦çºç48åä¸2å
ã»ããå¦é«ãªã¹ã¯ç¾¤ï¼25å
ã»æ£å¸¸ç¾¤ï¼21å
âé¢é£å å
ã»æè¡ä¾µè¥²ã大ãã
ã»è¡å¾è²§è¡ç¶æ ã«ãã
ã»ãã¬ã¼ã³ã»ã«ã¼ãé¡ãå¤ãæ¿å ¥ããã¦ãã
ï¼é«é½¢æè¡æ£è ã®ããå¦çºçè¦å ã«é¢ããæ¤è¨ãå¯å±±å»ç§è¬ç§å¤§å¦çè·å¦ä¼ã2005.7ï¼
Â
ã»å¼å¸å¨ç¾æ£æ£è
ã»65æ³ä»¥ä¸43å
ã»ããå¦è©ä¾¡å°ºåº¦ï¼ãã¼ã¹çï¼
ã»12ç¹ä»¥ä¸ãããå¦ç¾¤
ã»13åï¼30.2%ï¼ãããå¦
ã»ããå¦ç¾¤ã¨éããå¦ç¾¤ãæ¯è¼
ã»èªç¥çãå¼å¸å¨çç¶ã§ææå·®
âé¢é£å å
ã»å¹´é½¢
ã»èªç¥ç
ã»å¼å¸å¨çç¶
ã»è´è¦é害
ï¼é«é½¢æå¼å¸å¨ç¾æ£æ£è ã®ããå¦çºçã«é¢é£ããè¦å ã¨çºçãã¿ã¼ã³ã®ç¹å¾´ãç¦å²¡å¤§å»ç´ã38ï¼4ï¼,187-194,2011ï¼
Â
ã»å ¨èº«éº»é ä¸ã§ã®æ´å½¢æè¡
ã»65æ³ä»¥ä¸ã187å
ã»NEECHAM
ã»ããå¦ç¾¤15å
ã»å¹³å80.4æ³
âé¢é£å å
ã»å¹´é½¢
ã»èªç¥çã®æ¢å¾
ã»H2ãããã«ã¼ï¼æ³¨å°ï¼ã®ä½¿ç¨
ã»è´åé害
ã»è¡ä¸ã®åºè¡é
ã»è¡å¾ã®ä½åå¶é
ï¼æ´å½¢å¤ç§ç æ£ã®é«é½¢æ£è ã«ãããè¡å¾ããå¦çºçè¦å ã®æ¤è¨ãç¥å¤§é¢ä¿å¥ç´è¦ã第25å·» 2009ï¼
Â
ã»æ³å°¿å¨ç§æè¡æ£è
ã»65æ³ä»¥ä¸ã502å
ã»ããå¦çºç22å
ã»çºççï¼
ããè °æ¤éº»é ï¼2.2%
ããå ¨èº«éº»é ï¼17.1%
ã»çºçãã¼ã¯ï¼
ããå ¨èº«éº»é ï¼è¡å¾2-3æ¥
ããè °æ¤éº»é ï¼è¡å½æ¥
âé¢é£å å
ã»ä¸ç ã»æ¼å¤é転
ã»è¦è¦é害è
ã»é®çã»é®éå¤ã®ä½¿ç¨
ï¼é«é½¢æè¡æ£è ã®è¡å¾ããå¦çºççã¨çºçç¶æ³ã®åæã«é¢ããç 究ã群馬ä¿å¥å¦ç´è¦ã23:109-116,2002ï¼
Â
ã»å¤§è ¿éª¨é é¨éª¨ææ£è
ã»71åãå¹³å80.7æ³
ã»ããå¦çºç19ä¾
ã»çºçç26.8%
ã»DRS
âé¢é£å å
ã»è¡åæèé害
ã»æãã¼ãã³ã½ã³è¬ãH2ãããã«ã¼ãæãã¤è¬ã®ä¸ç¨®è¬å¤
ï¼å¤§è ¿éª¨é é¨éª¨ææ£è ã«ãããè¡å¾ããå¦ã®äºæ¸¬ãå·å´å»ä¼èªã25ï¼2ï¼:97-104,1999ï¼
Â
å½é¢ã§èããããäºæ¸¬å å
ã»å¹´é½¢
ã»èªç¥çï¼HDS-Rï¼25ãMMSEï¼25ï¼
ã»æè¡ä¾µè¥²ï¼è²§è¡ãã«ã¼ãé¡ï¼
ã»æè¦é害ï¼è¦è¦ã»è´è¦é害ï¼
ã»ä½åå¶éï¼ä¸è¢éª¨æãå§è¿«éª¨æãTHAãªã©ï¼
Â
ããå¦ãæç¶ããã¨
ã»91人ï¼å¹³å79æ³ï¼ã®è¡å¾æ£è
ã»45%ãè¡å¾ãå復室å ã§ãæ©æããå¦ã
ã»å ¨ä½ã®ç´4åã®3ã¯å復室ã§çºç
ã»æ©æããå¦æ£è ã®39%ãä»è·æ½è¨ã«å ¥æ
ã»æ©æããå¦ã®ãªãæ£è ã§æ½è¨å ¥æããã®ã¯3%
ã»æ©æããå¦ãã¿ããããæè¡å½æ¥ã®è¡å¾ã¯æ£å¸¸ã ã£ãæ£è ã§ã¯ã26%ãéé¢å¾ã«æ½è¨ã«å ¥æ
ï¼Anesthesia & Analgesia, news release, July 24, 2013ï¼
Â
â»ããå¦ã®æéã¨æ»äº¡çã¯ææã«é¢é£
ï¼Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J RCCM 2009ï¼
Â
äºé²
1ï¼ç°å¢ã®èª¿æ´ãè¡ã
æ£è ã«ã¨ã£ã¦ãªãã¿ã®ããç åºç°å¢ãæ´ãã
å¨å²ã®äººãçè·å¸«ãªã©ã®äººçç°å¢ã«ããç·å¼µãåããã
é¨é³ãæ©æ¢°é³ã®è»½æ¸ãå³ãé©åãªç §æã«èª¿ç¯ãã
é¨å±ã®ç§»åãæå°éã«ãã
Â
2ï¼è¦è¦ãè´è¦ãªã©ãæè¦é®æãå°ãªããã
æ¥å¸¸ä½¿ã£ã¦ããç¼é¡ãè£è´å¨ã使ç¨ãã¦ããããæè¦æ å ±ãé®æããªã
æéãå ´æãããããããªæ å ±æä¾ããã
Â
3ï¼ä¸å®ã軽æ¸ãã
æ確ããã¤ç°¡æ½ãªã³ãã¥ãã±ã¼ã·ã§ã³ãå³ã
ç解åã«å¿ãã説æãè¡ã
Â
4ï¼å ¨èº«ç¶æ ã®ãã©ã³ã¹ãä¿ã¤
è±æ°´é²æ¢ãæ°´ååºç´ãã©ã³ã¹ ï¼æ°´åæåã«æ³¨æãæã
é»è§£è³ªãã©ã³ã¹ ï¼è¡æ¶²ãã¼ã¿ã«æ³¨æãæã
çã¿ ï¼çã¿ã®ããã¸ã¡ã³ããè¡ã
便ç§ã»ä¸ç¢ ï¼æ便ã®èª¿æ´ãè¡ã
è¬ã®å¯ä½ç¨ ï¼æ©æçºè¦ãã調æ´ãã
Â
5ï¼æ´»åã¨ä¼æ¯ã®ãã©ã³ã¹ï¼ç¡ç ã調ç¯ãã
æ¥ä¸ã®æ´»åãå¢ãããå¤éã®ç¡ç ãã¨ããããã«é æ ®ãã
å¿ è¦æãç å¤ã調æ´ãã
Â
6ï¼æææãã¨ã
åã姿å¢ã»ç¶æ ãé·æéç¶ããªã
æ©æé¢åºãå³ã
ã©ã¤ã³é¡ã®æ©ææå»ãå³ã
ï¼åèï¼ãããå¦ï¼Deliriumï¼ã«ã¤ãã¦ãåç°æãç¦å³¶çç«å»ç§å¤§å¦å»å¦é¨ç¥çµç²¾ç¥å»å¦è¬åº§ï¼
Â
ããå¦ã¸ã®äºé²çãè¡ãã¨
ã»é«é½¢è 852åï¼70æ³ä»¥ä¸ï¼
 ã»The Elder Life Program
ã»ä»å ¥ç¾¤ã¨é常ã±ã¢ç¾¤ãæ¯è¼
ã»6ã¤ã®å±éºè¦å ãèæ ®
ãèªç¥é害ãç¡ç é害ãéåæ©è½ä½ä¸ãè¦è¦é害ãè´è¦é害ãè±æ°´
ã»çºççã9.9%ï¼15%
ã»æ©æã®ã±ã¢ã¯éè¦
ï¼A multicomponent intervention to prevent delirium in hospitalized older patients.NEJM 1999ï¼340ï¼669-676ï¼
Â
ã¾ã¨ãï¼
ã»çºççã¯10ï½30%
ã»å¹´é½¢ãèªç¥çãæè¡ä¾µè¥²ãæè¦é害ãä½åå¶éãªã©ãäºæ¸¬å å
ã»å®æçã«è©ä¾¡ãè¡ãçµéã追ã
ã»ããå¦ãæç¶ããã¨èªå® 復帰çãä½ä¸
ã»äºé²ã¯èªçºè¦å ãå°ãªããããã¨
ã»ç æ£ã¹ã¿ããã¨ã®ååãå¿ è¦
Â
åèã«ããã¦ããã ãããµã¤ãï¼
å»å¦ç¥èã®æ´»ããæ¹ï¼http://gendamar.com/eldery/282/
ããããï¼âçè·å¸«ã®ããã®webãã¬ã¸ã³ by å»å¦æ¸é¢ï¼http://igs-kankan.com/article/2012/04/000583/
å¥åº·é·å¯¿ãããï¼http://www.tyojyu.or.jp/hp/page000000800/hpg000000773.htm
ãã«ã¹ãã¼ã¸ã£ãã³ï¼http://www.healthdayjapan.com/index.php?option=com_content&view=article&id=4600:2013812&catid=20&Itemid=98
Wikipediaï¼http://ja.wikipedia.org/wiki/%E3%81%9B%E3%82%93%E5%A6%84
Â
Â
Â